P649 Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)

I Visuri,Carl Eriksson,E Mårdberg,Olof Grip,Anders Gustavsson,Henrik Hjortswang,Pontus Karling,Scott M. Montgomery,Pär Myrelid,Ola Olén,Jonas F. Ludvigsson,Jonas Halfvarson

P649 Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)

2019

I Visuri
Carl Eriksson
E Mårdberg
Olof Grip
Anders Gustavsson
Henrik Hjortswang
Pontus Karling
Scott M. Montgomery
Pär Myrelid
Ola Olén
Jonas F. Ludvigsson
Jonas Halfvarson

Anti-TNF agent drug survival in patients with IBD : real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)

Keywords:

Physical therapy
Tumor necrosis factor alpha
Oncology
Diabetes mellitus
Drug
Internal medicine
Medicine
in patient
drug survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations